Pacifica Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-58
Closed -$2K 497
2022
Q3
$2K Hold
58
﹤0.01% 440
2022
Q2
$3K Hold
58
﹤0.01% 416
2022
Q1
$3K Hold
58
﹤0.01% 416
2021
Q4
$3K Hold
58
﹤0.01% 413
2021
Q3
$3K Hold
58
﹤0.01% 415
2021
Q2
$3K Hold
58
﹤0.01% 400
2021
Q1
$3K Buy
58
+9
+18% +$432 ﹤0.01% 360
2020
Q4
$2K Hold
49
﹤0.01% 351
2020
Q3
$2K Sell
49
-200
-80% -$10.3K ﹤0.01% 317
2020
Q2
$13K Buy
+249
New +$12.1K 0.01% 208
2020
Q1
Sell
-200
Closed -$10K 397
2019
Q4
$10K Buy
+200
New +$9.37K 0.01% 238

Other funds holding SNY

Pacifica Partners's SNY Position: Q4 2022 in Review

Pacifica Partners sold out of Sanofi (SNY) in Q4 2022, closing a stake of 58 shares — an estimated $2K sold.

Pacifica Partners first reported a position in SNY in Q4 2019 and held it in 11 quarters. The position peaked at $13K in Q2 2020. 643 funds tracked by Wall St. Rank hold SNY as of Q4 2022.

  • Pacifica Partners reported no remaining Sanofi position as of Q4 2022 after selling out during the quarter.
  • Pacifica Partners sold 58 Sanofi shares in Q4 2022, an estimated $2K.
  • Pacifica Partners first reported a position in Sanofi in Q4 2019 and held it in 11 quarters.
  • Pacifica Partners's Sanofi position peaked at $13K in Q2 2020.
  • 643 funds tracked by Wall St. Rank held Sanofi as of Q4 2022.

Based on Pacifica Partners's 13F filing for Q4 2022, filed 12 Jan 2023.